Intra-arterial thrombolysis via urokinase following reperfusion by endovascular thrombectomy for stroke does not affect survival without disability.
The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Individuals with high PLMs had significantly higher Fazekas and ARWMC total scores than those with a lower PLM index.
19h
MyChesCo on MSNFDA Approves Lifesaving Stroke Drug, Xarelto Generics, and Issues Urgent Testosterone WarningsThe U.S. Food and Drug Administration (FDA) has released several important updates addressing new medication approvals and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results